2017-18 Research Portfolio Summary
June 5, 2018 The Lupus Research Alliance is driven by one central goal — to improve the lives of people living with the disease, today and in the long term. We believe that scientific research is the most powerful way we can achieve this goal. Further, we believe that by both pushing the limits of scientific exploration and […]
Lupus Research Alliance Appoints Albert Roy as President and Chief Executive Officer
NEW YORK, NY. August 10, 2022 – The Lupus Research Alliance (LRA) is pleased to announce the appointment of Albert Roy to President and Chief Executive Officer effective September 6, 2022. Mr. Roy currently serves as Executive Director of Lupus Therapeutics, the clinical trial affiliate of the Lupus Research Alliance. He will succeed Kenneth M. […]
Research Contacts
Lupus Research Alliance LuCIN Clinical Trials Network Launches Inaugural Studies
NEW YORK, NY. October 31, 2017 — The Lupus Research Alliance today announced the first clinical trials to be conducted through its Lupus Clinical Investigators Network (LuCIN) aimed at discovering new treatments for the millions of people around the globe living with lupus. Recognizing the limited treatments for lupus, LuCIN was organized, managed and is […]
Breadth of Clinical Research Presented at the 2019 ACR/ARP Annual Meeting Brings Hope for New Lupus Treatments
November 14, 2019 The Lupus Research Alliance staff was on the ground at the 2019 ACR/ARP Annual Meeting and highly encouraged by the positive results reported for several potential new treatments that may help people with lupus. “The foundational work the Lupus Research Alliance and others have supported is beginning to bear fruit with potential […]
LRA Proudly Congratulates Research Colleagues for Appointments to National Academy of Medicine
October 21, 2021 The Lupus Research Alliance (LRA) is very proud to congratulate our research grantee Katherine Fitzgerald, PhD and Scientific Advisory Board member Mariana J. Kaplan, MD, on their appointments to the highly prestigious National Academy of Medicine (NAM). Both Drs. Fitzgerald and Kaplan are preeminent leaders in lupus and autoimmune disease research. Dr. […]
Research Committee of the Board
Statement in Response to Recent Nature Publication
The Lupus Research Alliance (LRA) is encouraged by the recent study, “Interferon subverts an AHR–JUN axis to promote CXCL13+ T cells in lupus”, funded in part by the LRA and published in the journal Nature, that identified a molecular pathway that promotes an imbalance of T cells leading to an overactive immune response in lupus. […]
Research
Learn about foundational research